The effect of hyperbaric oxygen therapy on the adverse effects of octreotide on wound healing

OBJECTIVEOctreotide, a long-acting somatostatin analogue, has been used in the treatment of various disorders. Octreotide has significant detrimental impacts upon wound healing. We tested the hypothesis that hyperbaric oxygen therapy may overcome octreotide-mediated suppression of wound healing. DES...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of gastroenterology & hepatology 2004-05, Vol.16 (5), p.475-478
Hauptverfasser: Yildiz, Senol, Uluutku, Haldun, Gunay, Alp, Yildirim, I2smail, Yildirim, Şukru, Gurbuz, Ahmet Kemal
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 478
container_issue 5
container_start_page 475
container_title European journal of gastroenterology & hepatology
container_volume 16
creator Yildiz, Senol
Uluutku, Haldun
Gunay, Alp
Yildirim, I2smail
Yildirim, Şukru
Gurbuz, Ahmet Kemal
description OBJECTIVEOctreotide, a long-acting somatostatin analogue, has been used in the treatment of various disorders. Octreotide has significant detrimental impacts upon wound healing. We tested the hypothesis that hyperbaric oxygen therapy may overcome octreotide-mediated suppression of wound healing. DESIGNProspective, randomised, parallel-group animal study. METHODSOperated rats were divided into four groups(1) controls, (2) octreotide therapy, (3) hyperbaric oxygen therapy and (4) combination of octreotide and hyperbaric oxygen therapy. Wound healing was assessed by breaking-strength measurements, hydroxyproline levels and fibrosis scores. RESULTSOctreotide decreased the breaking-strength measurements, hydroxyproline levels and fibrosis scores to 72%, 88% and 55%, respectively, of the control group. In the combination group, hyperbaric oxygen therapy increased breaking-strength measurements and hydroxyproline levels to 137% and 126%, respectively, of the control group. In the combination group, hyperbaric oxygen therapy tended to increase the fibrosis scores to 111% of the control group, but without statistical significance. CONCLUSIONHyperbaric oxygen therapy tends to reverse the octreotide-induced impairment of wound healing.
doi_str_mv 10.1097/00042737-200405000-00007
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00042737_200405000_00007</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15097040</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3867-9d055eafb6b6138527fa9a6c0c43170131705d68b81e113eeb9af9a618f568523</originalsourceid><addsrcrecordid>eNp1kV1PwyAUhonRuDn9C4YbL6tQCrSXZvErWeLNTLwxDaWHtdqVBTpn_710H-qNF8Ahed6TwwNCmJJrSjJ5QwhJYslkFIeC8HCNwiLyCI1pIlnERSqP0ZhkPIlERl9H6Mz7d0KoZFSeohHloUtIjtHbvAIMxoDusDW46lfgCuVqje1Xv4AWdxU4teqx3ZZYlZ_g_CHih4zVnQPb1SUM0Mau2xJXoJq6XZyjE6MaDxf7c4Je7u_m08do9vzwNL2dRZqlQkZZSTgHZQpRCMpSHkujMiU00UmYl9Bh46VIi5QCpQygyJQJAE1NeCmP2QSlu77aWe8dmHzl6qVyfU5JPhjLD8byH2P51liIXu6iq3WxhPI3uFcUgKs9oLxWjXGq1bX_wwmZxiIJXLLjNrbpgqOPZr0Blw8muir_78fYNwvhguk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The effect of hyperbaric oxygen therapy on the adverse effects of octreotide on wound healing</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Yildiz, Senol ; Uluutku, Haldun ; Gunay, Alp ; Yildirim, I2smail ; Yildirim, Şukru ; Gurbuz, Ahmet Kemal</creator><creatorcontrib>Yildiz, Senol ; Uluutku, Haldun ; Gunay, Alp ; Yildirim, I2smail ; Yildirim, Şukru ; Gurbuz, Ahmet Kemal</creatorcontrib><description>OBJECTIVEOctreotide, a long-acting somatostatin analogue, has been used in the treatment of various disorders. Octreotide has significant detrimental impacts upon wound healing. We tested the hypothesis that hyperbaric oxygen therapy may overcome octreotide-mediated suppression of wound healing. DESIGNProspective, randomised, parallel-group animal study. METHODSOperated rats were divided into four groups(1) controls, (2) octreotide therapy, (3) hyperbaric oxygen therapy and (4) combination of octreotide and hyperbaric oxygen therapy. Wound healing was assessed by breaking-strength measurements, hydroxyproline levels and fibrosis scores. RESULTSOctreotide decreased the breaking-strength measurements, hydroxyproline levels and fibrosis scores to 72%, 88% and 55%, respectively, of the control group. In the combination group, hyperbaric oxygen therapy increased breaking-strength measurements and hydroxyproline levels to 137% and 126%, respectively, of the control group. In the combination group, hyperbaric oxygen therapy tended to increase the fibrosis scores to 111% of the control group, but without statistical significance. CONCLUSIONHyperbaric oxygen therapy tends to reverse the octreotide-induced impairment of wound healing.</description><identifier>ISSN: 0954-691X</identifier><identifier>EISSN: 1473-5687</identifier><identifier>DOI: 10.1097/00042737-200405000-00007</identifier><identifier>PMID: 15097040</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins, Inc</publisher><subject>Animals ; Biological and medical sciences ; Gastroenterology. Liver. Pancreas. Abdomen ; Hyperbaric Oxygenation ; Male ; Medical sciences ; Octreotide - adverse effects ; Random Allocation ; Rats ; Rats, Wistar ; Vasoconstrictor Agents - adverse effects ; Wound Healing - drug effects</subject><ispartof>European journal of gastroenterology &amp; hepatology, 2004-05, Vol.16 (5), p.475-478</ispartof><rights>2004 Lippincott Williams &amp; Wilkins, Inc.</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3867-9d055eafb6b6138527fa9a6c0c43170131705d68b81e113eeb9af9a618f568523</citedby><cites>FETCH-LOGICAL-c3867-9d055eafb6b6138527fa9a6c0c43170131705d68b81e113eeb9af9a618f568523</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15678264$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15097040$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yildiz, Senol</creatorcontrib><creatorcontrib>Uluutku, Haldun</creatorcontrib><creatorcontrib>Gunay, Alp</creatorcontrib><creatorcontrib>Yildirim, I2smail</creatorcontrib><creatorcontrib>Yildirim, Şukru</creatorcontrib><creatorcontrib>Gurbuz, Ahmet Kemal</creatorcontrib><title>The effect of hyperbaric oxygen therapy on the adverse effects of octreotide on wound healing</title><title>European journal of gastroenterology &amp; hepatology</title><addtitle>Eur J Gastroenterol Hepatol</addtitle><description>OBJECTIVEOctreotide, a long-acting somatostatin analogue, has been used in the treatment of various disorders. Octreotide has significant detrimental impacts upon wound healing. We tested the hypothesis that hyperbaric oxygen therapy may overcome octreotide-mediated suppression of wound healing. DESIGNProspective, randomised, parallel-group animal study. METHODSOperated rats were divided into four groups(1) controls, (2) octreotide therapy, (3) hyperbaric oxygen therapy and (4) combination of octreotide and hyperbaric oxygen therapy. Wound healing was assessed by breaking-strength measurements, hydroxyproline levels and fibrosis scores. RESULTSOctreotide decreased the breaking-strength measurements, hydroxyproline levels and fibrosis scores to 72%, 88% and 55%, respectively, of the control group. In the combination group, hyperbaric oxygen therapy increased breaking-strength measurements and hydroxyproline levels to 137% and 126%, respectively, of the control group. In the combination group, hyperbaric oxygen therapy tended to increase the fibrosis scores to 111% of the control group, but without statistical significance. CONCLUSIONHyperbaric oxygen therapy tends to reverse the octreotide-induced impairment of wound healing.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Hyperbaric Oxygenation</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Octreotide - adverse effects</subject><subject>Random Allocation</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Vasoconstrictor Agents - adverse effects</subject><subject>Wound Healing - drug effects</subject><issn>0954-691X</issn><issn>1473-5687</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kV1PwyAUhonRuDn9C4YbL6tQCrSXZvErWeLNTLwxDaWHtdqVBTpn_710H-qNF8Ahed6TwwNCmJJrSjJ5QwhJYslkFIeC8HCNwiLyCI1pIlnERSqP0ZhkPIlERl9H6Mz7d0KoZFSeohHloUtIjtHbvAIMxoDusDW46lfgCuVqje1Xv4AWdxU4teqx3ZZYlZ_g_CHih4zVnQPb1SUM0Mau2xJXoJq6XZyjE6MaDxf7c4Je7u_m08do9vzwNL2dRZqlQkZZSTgHZQpRCMpSHkujMiU00UmYl9Bh46VIi5QCpQygyJQJAE1NeCmP2QSlu77aWe8dmHzl6qVyfU5JPhjLD8byH2P51liIXu6iq3WxhPI3uFcUgKs9oLxWjXGq1bX_wwmZxiIJXLLjNrbpgqOPZr0Blw8muir_78fYNwvhguk</recordid><startdate>200405</startdate><enddate>200405</enddate><creator>Yildiz, Senol</creator><creator>Uluutku, Haldun</creator><creator>Gunay, Alp</creator><creator>Yildirim, I2smail</creator><creator>Yildirim, Şukru</creator><creator>Gurbuz, Ahmet Kemal</creator><general>Lippincott Williams &amp; Wilkins, Inc</general><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200405</creationdate><title>The effect of hyperbaric oxygen therapy on the adverse effects of octreotide on wound healing</title><author>Yildiz, Senol ; Uluutku, Haldun ; Gunay, Alp ; Yildirim, I2smail ; Yildirim, Şukru ; Gurbuz, Ahmet Kemal</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3867-9d055eafb6b6138527fa9a6c0c43170131705d68b81e113eeb9af9a618f568523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Hyperbaric Oxygenation</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Octreotide - adverse effects</topic><topic>Random Allocation</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Vasoconstrictor Agents - adverse effects</topic><topic>Wound Healing - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yildiz, Senol</creatorcontrib><creatorcontrib>Uluutku, Haldun</creatorcontrib><creatorcontrib>Gunay, Alp</creatorcontrib><creatorcontrib>Yildirim, I2smail</creatorcontrib><creatorcontrib>Yildirim, Şukru</creatorcontrib><creatorcontrib>Gurbuz, Ahmet Kemal</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>European journal of gastroenterology &amp; hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yildiz, Senol</au><au>Uluutku, Haldun</au><au>Gunay, Alp</au><au>Yildirim, I2smail</au><au>Yildirim, Şukru</au><au>Gurbuz, Ahmet Kemal</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effect of hyperbaric oxygen therapy on the adverse effects of octreotide on wound healing</atitle><jtitle>European journal of gastroenterology &amp; hepatology</jtitle><addtitle>Eur J Gastroenterol Hepatol</addtitle><date>2004-05</date><risdate>2004</risdate><volume>16</volume><issue>5</issue><spage>475</spage><epage>478</epage><pages>475-478</pages><issn>0954-691X</issn><eissn>1473-5687</eissn><abstract>OBJECTIVEOctreotide, a long-acting somatostatin analogue, has been used in the treatment of various disorders. Octreotide has significant detrimental impacts upon wound healing. We tested the hypothesis that hyperbaric oxygen therapy may overcome octreotide-mediated suppression of wound healing. DESIGNProspective, randomised, parallel-group animal study. METHODSOperated rats were divided into four groups(1) controls, (2) octreotide therapy, (3) hyperbaric oxygen therapy and (4) combination of octreotide and hyperbaric oxygen therapy. Wound healing was assessed by breaking-strength measurements, hydroxyproline levels and fibrosis scores. RESULTSOctreotide decreased the breaking-strength measurements, hydroxyproline levels and fibrosis scores to 72%, 88% and 55%, respectively, of the control group. In the combination group, hyperbaric oxygen therapy increased breaking-strength measurements and hydroxyproline levels to 137% and 126%, respectively, of the control group. In the combination group, hyperbaric oxygen therapy tended to increase the fibrosis scores to 111% of the control group, but without statistical significance. CONCLUSIONHyperbaric oxygen therapy tends to reverse the octreotide-induced impairment of wound healing.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins, Inc</pub><pmid>15097040</pmid><doi>10.1097/00042737-200405000-00007</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0954-691X
ispartof European journal of gastroenterology & hepatology, 2004-05, Vol.16 (5), p.475-478
issn 0954-691X
1473-5687
language eng
recordid cdi_crossref_primary_10_1097_00042737_200405000_00007
source MEDLINE; Journals@Ovid Complete
subjects Animals
Biological and medical sciences
Gastroenterology. Liver. Pancreas. Abdomen
Hyperbaric Oxygenation
Male
Medical sciences
Octreotide - adverse effects
Random Allocation
Rats
Rats, Wistar
Vasoconstrictor Agents - adverse effects
Wound Healing - drug effects
title The effect of hyperbaric oxygen therapy on the adverse effects of octreotide on wound healing
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T07%3A24%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effect%20of%20hyperbaric%20oxygen%20therapy%20on%20the%20adverse%20effects%20of%20octreotide%20on%20wound%20healing&rft.jtitle=European%20journal%20of%20gastroenterology%20&%20hepatology&rft.au=Yildiz,%20Senol&rft.date=2004-05&rft.volume=16&rft.issue=5&rft.spage=475&rft.epage=478&rft.pages=475-478&rft.issn=0954-691X&rft.eissn=1473-5687&rft_id=info:doi/10.1097/00042737-200405000-00007&rft_dat=%3Cpubmed_cross%3E15097040%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/15097040&rfr_iscdi=true